PubMed

Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease.

Jafar TH, Schmid CH, Levey AS.

Ann Intern Med. 2002 Aug 20;137(4):298-9. No abstract available. PMID: 12186531 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a pooled analysis of individual-patient data from 11 randomized, controlled trials.

Schrier RW, Estacio RO.

Ann Intern Med. 2001 Jul 17;135(2):138-9. No abstract available. PMID: 11453714 [PubMed - indexed for MEDLINE]Related articlesFree article

Angiotensin converting enzyme inhibitors in nondiabetic renal disease.

Maschio G, Marcantoni C.

Curr Opin Nephrol Hypertens. 1998 May;7(3):253-7. Review.PMID: 9617554 [PubMed - indexed for MEDLINE]Related articles

[Angiotensin converting enzyme inhibitors in renal diseases]

Shestakova MV, Kutyrina IM.

Kardiologiia. 2002;42(9):74-9. Russian. PMID: 12494080 [PubMed - indexed for MEDLINE]Related articles

Angiotensin-converting enzyme inhibitor for slowing progression of diabetic and nondiabetic kidney disease.

Myers BD, Boothroyd D, Olshen RA.

J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S66-70. Review.PMID: 11443771 [PubMed - indexed for MEDLINE]Related articles

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group.

Ann Intern Med. 2003 Aug 19;139(4):244-52.PMID: 12965979 [PubMed - indexed for MEDLINE]Related articlesFree article

Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.

Fernandez-Juárez G, Barrio V, de Vinuesa SG, Goicoechea M, Praga M, Luño J.

J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S250-4. Review.PMID: 17130270 [PubMed - indexed for MEDLINE]Related articlesFree article

Remission of renal disease: recounting the challenge, acquiring the goal.

Brenner BM.

J Clin Invest. 2002 Dec;110(12):1753-8. Review. No abstract available. PMID: 12488422 [PubMed - indexed for MEDLINE]Related articlesFree article

Progressive chronic nephropathy. With special emphasis on the influence of angiotensin converting enzyme inhibition.

Kamper AL.

Dan Med Bull. 1998 Apr;45(2):181-94. Review. No abstract available. PMID: 9587702 [PubMed - indexed for MEDLINE]Related articles

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

[No authors listed]

Prescrire Int. 2005 Oct;14(79):180-6.PMID: 16285075 [PubMed - indexed for MEDLINE]Related articles

ACE inhibitors and ARBs: are they better than other agents to slow nephropathy progression?

Bakris GL.

J Clin Hypertens (Greenwich). 2007 Jun;9(6):413-5. No abstract available. PMID: 17541325 [PubMed - indexed for MEDLINE]Related articles

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney.

Thurman JM, Schrier RW.

Am J Med. 2003 May;114(7):588-98. Review.PMID: 12753883 [PubMed - indexed for MEDLINE]Related articles

[Diabetic nephropathy and ACE inhibitors]

Amann B.

Clin Res Cardiol. 2006 Jan;95 Suppl 1:i83-7. German. PMID: 16598556 [PubMed - indexed for MEDLINE]Related articles

Use of angiotensin-converting enzyme inhibitors in patients with diabetic and nondiabetic chronic renal diseases: a need for reassessment.

Jaichenko J, Fudin R, Shostak A, Gotloib L.

Nephron. 1998 Nov;80(3):367-8. No abstract available. PMID: 9807055 [PubMed - indexed for MEDLINE]Related articles

Compelling drug indications in diabetic and nondiabetic nephropathy.

Ritz E, Dikow R, Zeier M.

Curr Hypertens Rep. 2004 Aug;6(4):293-9. Review.PMID: 15257864 [PubMed - indexed for MEDLINE]Related articles

The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises.

Schieppati A, Remuzzi G.

Kidney Int. 2003 Dec;64(6):1947-55. No abstract available. PMID: 14633117 [PubMed - indexed for MEDLINE]Related articles

WITHDRAWN: Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.

Lovell HG.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD002183. Review.PMID: 17636698 [PubMed - indexed for MEDLINE]Related articles

Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.

Kanno Y, Takenaka T, Nakamura T, Suzuki H.

Clin J Am Soc Nephrol. 2006 Jul;1(4):730-7. Epub 2006 May 17.PMID: 17699280 [PubMed - indexed for MEDLINE]Related articlesFree article

Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?

Vogt L, Kocks MJ, Laverman GD, Navis G.

Minerva Med. 2004 Oct;95(5):395-409. Review.PMID: 15467515 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease.

Jafar TH, Stark PC, Schmid CH, Strandgaard S, Kamper AL, Maschio G, Becker G, Perrone RD, Levey AS; ACE Inhibition in Progressive Renal Disease (AIPRD) Study Group.

Kidney Int. 2005 Jan;67(1):265-71.PMID: 15610250 [PubMed - indexed for MEDLINE]Related articles